Bafna Pharmaceuticals has informed that the board of directors of the company at its meeting held on September 15, 2012, has allotted 1,50,000 equity shares pursuant to conversion of warrants into equity shares after receipt of 75% of balance money, warrants allotted on March 17, 2011.
Further, cancelled 20,43,000 convertible warrants allotted on March 17, 2011 for non payment of balance money within 18 months and forfeited the 25% (application) money paid at the time of allotment of warrants. The paid-up share capital of the company increased to Rs. 18,65,63,350 comprising of 1,86,56,335 equity shares of Rs 10 each.
The above information is a part of company's filings submitted to BSE.
